FFCP PHASE2:Hg19::chr14:21852189..21852206,-
From FANTOM5_SSTAR
Jump to: navigation, search
Short description: | p3@SUPT16H |
---|---|
Species: | Human (Homo sapiens) |
DPI dataset: | Robust |
TSS-like-by-RIKEN-classifier(Yes/No): | Yes |
DHS support(Yes/No): | Yes |
Description: | CAGE_peak_3_at_SUPT16H_5end |
Coexpression cluster: | C3407_hepatocellular_rhabdomyosarcoma_myxofibrosarcoma_acute_Burkitt_retinoblastoma_teratocarcinoma |
Association with transcript: | -17bp_to_ENST00000555752_5end |
EntrezGene: | SUPT16H |
HGNC: | 11465 |
UniProt: | NA |
Genome view: | ZENBU |
View on UCSC genome browser
CAGE Expression
Sample | p3@SUPT16H |
---|
0
5
10
15
20
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
cancer | 1.30e-33 | 235 |
disease of cellular proliferation | 6.31e-33 | 239 |
cell type cancer | 2.23e-21 | 143 |
carcinoma | 2.06e-16 | 106 |
organ system cancer | 6.29e-16 | 137 |
hematologic cancer | 9.29e-13 | 51 |
immune system cancer | 9.29e-13 | 51 |
leukemia | 1.26e-09 | 39 |
myeloid leukemia | 4.60e-08 | 31 |
Showing 1 to 9 of 9 entries